[Haemodynamic effects following preoperative hypervolemic haemodilution with hypertonic hyperoncotic colloid solutions in coronary artery bypass graft surgery]
- PMID: 14618246
- DOI: 10.1007/s00101-003-0568-x
[Haemodynamic effects following preoperative hypervolemic haemodilution with hypertonic hyperoncotic colloid solutions in coronary artery bypass graft surgery]
Abstract
Objective: Using hyperoncotic colloids as volume replacement to provide haemodynamic stability appears to be a suitable approach to diminish fluid overload and subsequent interstitial edema during cardiac surgery. The aim of the present study was to investigate for the first time the haemodynamic effects following preoperative haemodilution with different hypertonic hyperoncotic colloid solutions in patients undergoing coronary artery bypass grafting.
Methods: A total of 43 patients with normal left ventricular ejection fraction, undergoing elective coronary artery bypass grafting received preoperatively after induction of anaesthesia according to randomisation the following solutions: 1: 750 ml/m(2) (body surface area) NaCl 0.9% ( n=10, control group, NACL), 2: 250 ml/m(2) 10% HES 200/0.5 plus 400 ml/m(2) NaCl 0.9% ( n=9, HES), 3: 250 ml/m(2) 10% dextran 40 plus 300 ml/m(2) NaCl 0.9% ( n=8, DEX), 4: 150 ml/m(2) hypertonic NaCl (7.2%) 10% HES 200/0.5 (n=8, HYPER-HES), 5: 150 ml/m(2) hypertonic NaCl (7.2%) 10% dextran 60 ( n=8, HYPER-DEX). Haemodynamic measurements were performed immediately before and 15 min after haemodilution and up to 60 min after termination of extracorporeal circulation in 10 min intervals. Fluid balances were calculated separately, during the time period of surgery, postoperatively up to 24 h after termination of surgery, and during the course of extracorporeal circulation.
Results: After haemodilution with colloid solutions, a marked increase was observed in all patients and with HYPER-HES and HYPER-DEX a statistically significant increase in cardiac index (CI: +38%, +54%), stroke volume index (SVI: +42%, +40%), and oxygen availability (DO2: +34%; +41%), respectively, was observed during the pre-bypass period. At the same time right and left ventricular filling pressures increased slightly in all patients but these changes did not differ among the treatment groups. Heart rate and mean arterial pressure remained almost unchanged in all groups. The amount of crystalloid solutions required by the patients during surgery was markedly decreased with HES and DEX and significantly decreased with HYPER-HES and HYPER-DEX (1,013+/-341 ml/m(2), 1,096+/-234 ml/m(2)) compared to the control group NACL (1629+/-426 ml/m(2)). Serum sodium concentrations increased with HYPER-HES and HYPER-DEX to maximal values of 150+/-3 mmol/l and 149+/-4 mmol/l, respectively (baseline 141+/-3 mmol/l, 141+/-1 mmol/l)
Conclusions: Compared to isotonic saline solution, preoperative volume replacement with hyperoncotic colloids improves haemodynamic conditions during the pre-bypass period in patients with normal left ventricular function undergoing coronary artery bypass grafting. Additionally intraoperative crystalloid solution requirements are reduced. The volume saving effects are increased with administration of hyperoncotic colloids in a preparation with hypertonic saline solution, whereas the choice of the colloid, either hydroxyethyl starch or dextran seems to be of minor importance.
Similar articles
-
Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.Pediatrics. 2006 Jul;118(1):e76-84. doi: 10.1542/peds.2005-2795. Epub 2006 Jun 2. Pediatrics. 2006. PMID: 16751617 Clinical Trial.
-
[Hypertonic-hyperoncotic volume replacement (7.5% NaCl/10% hydroxyethyl starch 200.000/0.5) in patients with coronary artery stenoses].Zentralbl Chir. 1993;118(5):257-63; discussion 264-6. Zentralbl Chir. 1993. PMID: 7686707 Clinical Trial. German.
-
Effects of hyperoncotic or hypertonic-hyperoncotic solutions on polymorphonuclear neutrophil count, elastase- and superoxide-anion production: a randomized controlled clinical trial in patients undergoing elective coronary artery bypass grafting.Acta Anaesthesiol Scand. 2007 Aug;51(7):914-21. doi: 10.1111/j.1399-6576.2007.01341.x. Epub 2007 Jun 18. Acta Anaesthesiol Scand. 2007. PMID: 17578462 Clinical Trial.
-
[Volume replacement solutions--pharmacology and clinical use].Anasthesiol Intensivmed Notfallmed Schmerzther. 1998 Jan;33(1):2-17. doi: 10.1055/s-2007-994204. Anasthesiol Intensivmed Notfallmed Schmerzther. 1998. PMID: 9530478 Review. German.
-
[Colloidal hypertonic solutions in cardiac surgery].Zentralbl Chir. 1993;118(5):250-6. Zentralbl Chir. 1993. PMID: 7686706 Review. German.
Cited by
-
Effects of rapid fluid infusion on hemoglobin concentration: a systematic review and meta-analysis.Crit Care. 2022 Oct 23;26(1):324. doi: 10.1186/s13054-022-04191-x. Crit Care. 2022. PMID: 36274172 Free PMC article.
-
Operating room use of hypertonic solutions: a clinical review.Clinics (Sao Paulo). 2008 Dec;63(6):833-40. doi: 10.1590/s1807-59322008000600021. Clinics (Sao Paulo). 2008. PMID: 19061009 Free PMC article. Review.
-
Comparison of 7.2% hypertonic saline - 6% hydroxyethyl starch solution and 6% hydroxyethyl starch solution after the induction of anesthesia in patients undergoing elective neurosurgical procedures.Clinics (Sao Paulo). 2013;68(3):323-8. doi: 10.6061/clinics/2013(03)oa07. Clinics (Sao Paulo). 2013. PMID: 23644851 Free PMC article. Clinical Trial.
-
The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis.Crit Care. 2014 Dec 4;18(6):656. doi: 10.1186/s13054-014-0656-0. Crit Care. 2014. PMID: 25475406 Free PMC article.
-
Recommendations for the use of albumin and immunoglobulins.Blood Transfus. 2009 Jul;7(3):216-34. doi: 10.2450/2009.0094-09. Blood Transfus. 2009. PMID: 19657486 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical